<DOC>
	<DOCNO>NCT00319683</DOCNO>
	<brief_summary>5-fluorouracil ( 5-FU ) , one actively investigate anti-cancer drug , rapidly inactivate enzyme dihydropyrimidine dehydrogenase ( DPD ) . ADH300004 block DPD . This study test safety effect oral ADH300004 14 hour prior oral 5-FU subject locally advance , recurrent , metastatic hepatocellular carcinoma .</brief_summary>
	<brief_title>A Study ADH300004 5-Fluorouracil Locally Advanced , Recurrent , Metastatic Hepatocellular Carcinoma</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Hepatocellular</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<mesh_term>Eniluracil</mesh_term>
	<criteria>Signed write informed consent In Phase I portion , Asian subject &gt; = 18 year age In Phase II portion , subject &gt; = 18 year age Nonresectable locally advance , recurrent , metastatic hepatocellular carcinoma ( HCC ) either histologically proven radiologically document liver mass : ( alphafetoprotein [ AFP ] &gt; 4,000 ng/mL , hepatitis B surface antigen positive alphafetoprotein [ AFP ] &gt; 400 ng/mL , hepatitis B surface antigen negative ) Radiologically document measurable disease Adequate performance status organ function , evidence hematologic biochemical blood test Willing receive fluoropyrimidine contain chemotherapy 8 week last dose ADH300004 study Chemotherapy , radiotherapy , investigational drug within 28 day prior study entry No 1 previous treatment systemic chemotherapy ( chemotherapy administer part chemoembolization procedure consider systemic chemotherapy ) Portal hypertension bleed esophageal gastric varix within past 3 month Ascites refractory conservative management Inability take oral medication Active peptic ulcer disease Known hypersensitivity 5FU ADH300004 History primary brain tumor brain metastasis Previous concurrent malignancy another site within last 5 year Stroke , major surgery , major tissue injury within 30 day study entry</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2008</verification_date>
	<keyword>Cancer</keyword>
	<keyword>Tumors</keyword>
	<keyword>Neoplasms</keyword>
	<keyword>Anticarcinogenic Agents</keyword>
	<keyword>Antineoplastic Agents</keyword>
	<keyword>Dihydrouracil Dehydrogenase ( NADP )</keyword>
</DOC>